Sentences with phrase «immune system therapies»

Genetic Vaccine Helps Immune System Researchers Dr. H. Kim Lyerly and Eli Gilboa from Duke University's Center for Genetic and Cellular Therapies in Durham, NC, are studying the safety and effectiveness of a new immune system therapy called a genetic vaccine.

Treatment can include Polymodal therapy (polymodal nerve cells line the liver), immunomodulation (immune system therapy), antioxidants, Vitamin E, Silibinin (stunts the growth of tumors), polyunsaturated phosphatidylcholine (fatty acid) or colchicine (derived from a plant).

Not exact matches

One setback for these therapies which use the body's immune system to fight cancers is that they are, at times, more effective in certain patient pools than others.

For example, we've seen new discoveries in health care recently, especially in immuno - oncology therapies, which help the immune systems of cancer patients recognize and destroy cancerous cells.

Massage Therapy is delivered to improve the flow of blood and lymph (fluid in lymph glands, part of immune system), to reduce muscular tension or flaccidity, to affect the nervous system through stimulation or sedation, and to enhance tissue healing.

A randomized placebo - controlled trial of massage therapy on the immune system of preterm infants.

She will have a stronger immune system, for instance, and will be much less likely to need orthodontia or speech therapy.

Non-lactational mastitis occurs in women with weakened immune systems, including women who have had lumpectomies with radiation therapy and women with diabetes.

During the sessions, U.S. and Cuban scientists explored such topics as the molecular mechanisms cancer cells employ to evade the body's immune system, new tools to image and manipulate that system, and ways to rethink how such therapies can best be deployed to reach patients where they receive health services.

A group of the nation's leading cancer research scientists and their Cuban counterparts are exploring how to advance cancer therapy, diagnosis, and prevention, including the use of immunotherapy to harness the body's immune systems to attack and eliminate cancer cells.

«This approach will hopefully lead to better mechanistic predictive modeling of response and future design of therapies that further take advantage of how the immune system recognizes tumors.»

Revving up the immune system to combat a wide variety of tumor types may take cancer therapy in a new direction, says Khaled Barakat, a computational scientist at the University of Alberta in Canada, who was not involved in the study.

A type of immune therapy known as PD - 1 blockade controlled cancer in 77 percent of patients with defects in DNA mismatch repair — the system cells use to spell - check and fix errors in DNA (SN Online: 10/7/15).

Side effects of the treatment included skin rashes, thyroid problems and diarrhea as the therapy caused the immune system to attack other parts of the body.

«If we know which genes are damaged in a breast cancer patient's immune system, prevention or even therapy can be tailored by giving vaccines or perhaps antiviral drugs to reduce the chances of recurrence,» said Friedenson.

Has anybody ever done anything like this — used gene therapy to modify the immune system?

«Current therapies in clinical trials are focused on targeting genetic changes in tumors and helping to boost one's immune system to fight the cancer cells.

More and more, Sweeney says, the immune system is proving to be the most difficult hurdle in developing gene therapy for humans.

The therapy gives the immune system the tools to flush out HIV, meaning daily drugs can be ditched — one man has been free of them for seven months

«Steep funding cuts for the federal health agencies are counterproductive at a time when innovative research is moving us closer to identifying solutions for rare diseases, new prevention strategies to protect Americans from deadly and costly conditions, advances in gene therapy, new technologies for understanding the brain, and treatments that harness the ability of our immune system to fight cancer.»

Patients with metastatic non-small cell lung cancer will always progress after chemotherapy, so most patients go on to be treated with immunotherapy, a type of therapy that uses the body's immune system to fight cancer.

«Our findings results suggest a new strategy for immune system - based therapies for cancer,» says the study's senior author, Harvey Cantor, MD, of Dana - Farber and Harvard.

«The findings also suggest that therapies targeting the immune system may be effective treatments against this disorder and possibly other forms of epilepsy,» said Nath.

Antibodies and T cells against the protein could cause the immune system to attack cells carrying it, making gene therapy ineffective.

For this study, researchers combined two therapies, each targeting a different part of the immune system.

Yet studies have shown single therapies targeting only one part of the immune system have been effective in only a small percentage of patients.

Treatments aimed at revving up the immune system's attack on the cancer may be the most promising approach to cancer therapy since combination chemotherapy.

«As a field, we are starting to grapple with premature aging in the HIV - infected population, even in patients who are on therapy — their immune systems largely look like someone whose immune system is many years older,» Hunt notes.

And early stage startup Neochromosome, which includes Boeke, intends to raise money to design synthetic chromosomes for medicine that could be used in an off - the - shelf universal cell line in cell therapies and transplants with minimal risk of rejection from the immune system.

Their findings suggest that therapies based on these compounds could help to treat rheumatoid arthritis, which occurs when the immune system attacks the joints, causing pain and swelling.

«Our study reveals a new mechanism that could be harnessed for biological therapies for lupus and other autoimmune diseases, where the immune system mistakenly targets the body's own cells,» says senior study author Boris Reizis, PhD, professor of Pathology and Medicine at NYU Langone.

EMD Serono, Kirschbaum says, «focuses on the development of targeted cancer therapies on three therapeutic platforms: targeting the tumor cell, the tumor environment, and the immune system.»

Researchers are developing many different versions of CAR - T cell therapies, but the basic premise is the same: Doctors remove a patient's T cells (immune system cells that attack invaders) from a blood sample and genetically modify them to produce artificial proteins on their surfaces.

HIV also hides in cells and continues to undermine the host's immune system despite antiretroviral therapy that has improved the outlook of those with AIDS.

A phase 3 trial of lenalidomide / dexamethasone with elotuzumab (Empliciti ™), an antibody therapy that attacks myeloma cells directly and spurs the immune system to launch an attack of its own.

With additional genome tinkering to avoid rejection by the immune system, they could be used clinically as a universal stem cell therapy.

At the moment a lot of therapies are focused on the site of infection or injury itself but this data suggests that it's the signals that are being sent out from the gut that are impacting the whole immune system.

Dr. Cripe and his colleagues at The Ohio State University, the University of Pittsburgh School of Medicine and Cincinnati Children's Hospital Medical Center tested how well the oncolytic viral therapy — a cancer - killing form of the herpes simplex virus, called oHSV — infected and killed tumor cells in mice with and without a healthy immune system.

So he joined GSK Vaccines in 2010, as a molecular biologist in the company's Antigen - Specific Cancer Immunotherapeutic program, which aims to harness the immune system for the development of well - tolerated cancer therapies.

Stamets furnished capsules of freeze - dried fungus for a seven - year, NIH - funded study by Bastyr University and the University of Minnesota to determine whether turkey tail mushrooms could help breast cancer patients whose immune systems had been compromised by radiation therapy.

Much of the cancer - killing effect of the oHSV injections was lost when the researchers tested the therapy in tumors of mice with defective immune systems.

Participants also continued to take immune system — modulating therapies known to reduce symptoms.

Despite these promising clinical implications, the team calls for additional research on the interplay between viral therapy, infectability and immune system response.

Epigenetic therapies are thought to work in two ways to fix these errors in cancer cells — by correcting the «position» of the gene switches and by making the cell appear as though it's infected by a virus, triggering the immune system.

Viral therapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients» immune systems, according to findings published today in the journal Molecular Therapy — Oncotherapy for childhood cancer could possibly improve if treatments such as chemotherapy do not first suppress patients» immune systems, according to findings published today in the journal Molecular Therapy — OncoTherapy — Oncolytics.

According to Dr. Cripe, the study suggests that some patients could respond to therapy even if their tumors aren't very infectable by the virus, provided their immune systems were stimulated by the viral therapy to attack the tumor cells.

Instead, the therapy may benefit from the activity of the immune system operating in tandem, creating a synergistic, cancer - killing effect.

Immune therapy for ovarian, breast and colorectal cancer — treatments that encourage the immune system to attack cancer cells as the foreign invaders they are — has so far had limited success, primarily because the immune system often can't destroy the cancer cells.

To help formulate effective therapies against MRSA, researchers need a better understanding of how the immune system can combat unyielding bacteria.

«We hope that this research showing GM - CSF is an important target will lead us toward therapies that more effectively block the damaging immune reaction in the central nervous system of MS patients,» says Dr. Rostami.